Could a stool sample someday help clinicians choose a diabetes medication before writing the prescription? Emerging research into gut biomarkers in diabetes is moving that possibility closer to clinical reality. Rather than simply cataloging which bacteria live in the intestine, researchers are examining microbial genes, stool-derived metabolites, and functional signatures …
Read More »Why Early Combination Therapy Is Gaining Momentum in Young-Onset Type 2 Diabetes
Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults. While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a “metformin-first and wait” strategy is enough for this higher-risk population. As research continues …
Read More »Cancer Therapy Is Changing Diabetes Management: What Clinicians Need to Know Now
Cancer treatment is evolving rapidly, and with that progress comes a new challenge for clinicians managing glucose disorders. As immune checkpoint inhibitors (ICIs) and PI3K inhibitors become more widely used in oncology, therapy-related hyperglycemia is appearing more often in clinical practice. Many patients receiving cancer treatment now face unexpected glucose …
Read More »Common Diabetes Drug Metformin Increases Egg Output in Chickens
Metformin, a common diabetes drug, boosts egg production in chickens, revealing potential new uses in poultry farming and agricultural efficiency.
Read More »The Role of Metformin in Diabetes Management: New Insights and Practical Tips
Discover new insights and practical tips on using Metformin in diabetes management, enhancing treatment efficacy and patient outcomes.
Read More »Metformin: Understanding Its Mechanisms and Clinical Applications
Metformin is a drug used to treat type 2 diabetes and other related medical conditions. It has been used for over 50 years and is one of the most widely prescribed medications in the world. It has been proven to be effective in controlling blood sugar levels and can also …
Read More »Patients with diabetes and HF on Metformin and Sulfonylurea show improved clinical outcomes
In patients with type 2 diabetes mellitus, composite mortality/HHF was significantly lower in patients taking metformin versus those taking sulfonylurea.The rising global burden of diabetes and its complications in recent years has called for new Prevention and control programs and alternative treatment approaches for existing treatments based on evidence-based treatment …
Read More »Treating CVD with DPP-4 Inhibitors vs. Sulphonylureas Plus Metformin
New retrospective study results compare the two most primarily prescribed antidiabetic medication classes in addition to metformin to determine the impact on the incidence of CV events in patients with T2DM.
Read More »Combination Therapy with Metformin and an SGLT2 Inhibitor
Black patients may have lower odds of achieving target HbA1C levels on metformin and SGLT2 alone.
Read More »Metformin or Sulfonylurea Use Significantly Lowered Risk of Mortality for COVID-19 Patients with T2D
Insulin is not recommended for COVID-19 patients with T2D due to increased mortality risk,
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.